Compugen
CGEN
38 hedge funds and large institutions have $52.7M invested in Compugen in 2014 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 7 closing their positions.
120% more capital invested
Capital invested by funds: $23.9M → $52.7M (+$28.7M)
29% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 7
19% more call options, than puts
Call options by funds: $325K | Put options by funds: $273K
6% more funds holding
Funds holding: 36 → 38 (+2)
25% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 12
Top Buyers
| 1 |
MTWSIF
Mivtachim The Workers Social Insurance Fund
Tel Aviv,
Israel
|
+$2.27M |
| 2 |
Jane Street
New York
|
+$600K |
| 3 |
LP
LMR Partners
London,
United Kingdom
|
+$288K |
| 4 |
U
UBS
Zurich,
Switzerland
|
+$280K |
| 5 |
PMG
ProVise Management Group
Clearwater,
Florida
|
+$106K |
Top Sellers
CGEN Hedge Fund Activity: Q3 2014 in Review
38 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Compugen (CGEN) for Q3 2014, worth a combined $52.7M — up 120% from $23.9M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new CGEN positions and 7 closed out — a net gain of 2 holders — while 9 added to existing stakes and 12 trimmed.
The largest buyer was Mivtachim The Workers Social Insurance Fund, opening a new position worth an estimated $2.27M. The largest seller was Renaissance Technologies, cutting an estimated $713K.
- 38 institutional investors held Compugen (CGEN) as of Q3 2014, up from 36 in Q2 2014.
- Funds reported $52.7M of Compugen stock for Q3 2014, up 120% quarter-over-quarter.
- 9 funds opened new Compugen positions in Q3 2014 and 7 closed out, a net change of +2 holders.
- The largest Compugen buyer in Q3 2014 was Mivtachim The Workers Social Insurance Fund, an estimated $2.27M added.
- The largest Compugen seller in Q3 2014 was Renaissance Technologies, an estimated $713K sold.
Based on aggregated 13F filings for Q3 2014.